Publicaciones (132) Publicaciones de Emilio José Sanz Álvarez

2023

  1. A Clinical Pharmacology and Therapeutics Teacher's Guide to Race-Based Medicine, Inclusivity, and Diversity

    Clinical Pharmacology and Therapeutics, Vol. 113, Núm. 3, pp. 600-606

  2. Adverse drug reactions and their fatal outcomes in clozapine patients in VigiBase: Comparing the top four reporting countries (US, UK, Canada and Australia)

    Schizophrenia Research

  3. An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance

    Schizophrenia Research

  4. An expert review of clozapine in Latin American countries: Use, monitoring, and pharmacovigilance

    Schizophrenia Research

  5. Analysis of deprescription strategies of proton pump inhibitors in primary care: A narrative review

    Primary Health Care Research and Development, Vol. 24

  6. Clozapine-associated pericarditis and pancreatitis in children and adolescents: A systematic literature review and pharmacovigilance study using the VigiBase database

    Schizophrenia Research

  7. Educational value of international and intercultural differences in prescribing: the international and interprofessional student-run clinic project

    European Journal of Clinical Pharmacology, Vol. 79, Núm. 4, pp. 571-574

  8. Escaping the Long Shadow Cast by Agranulocytosis: Reflections on Clozapine Pharmacovigilance Focused on the United Kingdom

    Journal of Clinical Psychopharmacology, Vol. 43, Núm. 3, pp. 239-245

  9. Functional Status of Patients over 65 Years Old Intervened on for a Hip Fracture One Year after the Operation

    Healthcare (Switzerland), Vol. 11, Núm. 10

  10. Knowledge, use and opinion about written informed consent in primary healthcare nurses: CONOSER pilot project

    Atencion Primaria, Vol. 55, Núm. 2

  11. Respiratory aspiration during treatment with clozapine and other antipsychotics: a literature search and a pharmacovigilance study in vigibase

    Expert Opinion on Drug Metabolism and Toxicology, Vol. 19, Núm. 2, pp. 57-74

  12. Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK

    Schizophrenia Research